Production (Stage)
Pacific Biosciences of California, Inc.
PACB
$1.14
$0.1414.00%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.27% | -32.79% | -28.23% | -24.30% | -0.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.27% | -32.79% | -28.23% | -24.30% | -0.23% |
| Cost of Revenue | 14.99% | -28.63% | -28.83% | -31.39% | -9.57% |
| Gross Profit | -44.22% | -45.44% | -26.99% | -9.95% | 26.96% |
| SG&A Expenses | -8.19% | 21.84% | -15.16% | -5.41% | 9.88% |
| Depreciation & Amortization | 5,249.50% | 0.01% | 640.54% | 3,643.17% | 3,642.62% |
| Other Operating Expenses | -- | -70.95% | -- | -- | -- |
| Total Operating Expenses | 290.70% | -11.15% | -25.87% | -16.09% | 1.99% |
| Operating Income | -431.28% | -3.46% | 24.09% | 10.61% | -3.08% |
| Income Before Tax | -445.39% | 103.25% | 21.72% | -148.19% | 11.18% |
| Income Tax Expenses | -- | 144.01% | -- | -- | -- |
| Earnings from Continuing Operations | -445.01% | 102.89% | 9.19% | -148.19% | 11.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -445.01% | 102.89% | 9.19% | -148.19% | 11.18% |
| EBIT | -431.28% | -3.46% | 24.09% | 10.61% | -3.08% |
| EBITDA | 14.33% | -4.08% | 35.71% | 21.78% | 6.14% |
| EPS Basic | -394.93% | 102.74% | 15.14% | -127.82% | 20.26% |
| Normalized Basic EPS | -376.47% | -0.15% | 28.55% | 13.37% | 5.17% |
| EPS Diluted | -396.55% | 102.65% | 15.14% | -128.57% | 20.26% |
| Normalized Diluted EPS | -376.47% | 7.65% | 28.55% | 13.37% | 5.17% |
| Average Basic Shares Outstanding | 10.12% | 5.94% | 7.03% | 8.92% | 11.38% |
| Average Diluted Shares Outstanding | 10.12% | 14.89% | 7.03% | 8.92% | 11.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |